Lael Stander, MD
Neurology · Colorado Springs, CONPI 1255693859
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $927 and has fallen 86.3% since, to $127 in 2024.
Across 62 payments — averaging $22.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$201
- Amgen$144
- Sanofi$132
- AbbVie$120
- SK Life Science, Inc.$112
- Biogen$105
- plus $610 from 20 others
What the payments were for
- Food & beverage$1,423100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 7 | $201 |
| Amgen | 4 | $144 |
| Sanofi | 5 | $132 |
| AbbVie(2 entities) | 7 | $120 |
| SK Life Science, Inc. | 1 | $112 |
| Biogen | 5 | $105 |
| CSL Behring | 3 | $104 |
| Supernus Pharmaceuticals, Inc. | 3 | $61 |
| UCB, Inc. | 3 | $61 |
| EMD Serono, Inc. | 4 | $55 |
| Acadia Pharmaceuticals Inc | 3 | $47 |
| Mallinckrodt Enterprises LLC | 2 | $32 |
| Lilly USA, LLC | 2 | $26 |
| AstraZeneca | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| GE HealthCare | 1 | $21 |
| Greenwich Biosciences, Inc. | 1 | $20 |
| Livanova USA, Inc. | 1 | $18 |
| Neurocrine Biosciences, Inc. | 1 | $16 |
| Kyowa Kirin, Inc. | 1 | $16 |
| Bausch Health US, LLC | 1 | $15 |
| Medtronic | 1 | $15 |
| MDD US Operations, LLC | 1 | $15 |
| Akcea Therapeutics, Inc. | 1 | $13 |
| Saol Therapeutics Inc. | 1 | $13 |
| Promius Pharma LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,423 in reported general payments places this provider in the 55th percentile of 334 neurology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Colorado Springs
- Kimberly WagnerColorado Springs$107K
- Brendan LindgrenColorado Springs$105K
- Bradley PriebeColorado Springs$100K
- Aparna KomatineniColorado Springs$71K
- Michelle RaphaelColorado Springs$19K
- Tamara MillerFort Collins$1.4M
- Justin MoonDenver$1.4M
- Ravi ShahParker$1.3M
- Rajeev KumarEnglewood$955K
- Marc TreihaftEnglewood$673K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.